K'ANNE CASH ARTHUR MD NPI 1144663923

NPI Details

K'anne Cash Arthur, MD is a hematology and oncology internal medicine in Fayetteville, AR with 13 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. K'anne Cash Arthur, MD NPI is 1144663923. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Graduation Year:2013

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1144663923 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, cemiplimab-rwlc, 1 mg (HCPCS:J9119)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Bilirubin level, direct (HCPCS:82248)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Ct scan of chest with contrast (HCPCS:71260)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Vitamin d-3 level (HCPCS:82306)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Unclassified drugs (HCPCS:J3490)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Folic acid level, serum (HCPCS:82746)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• X-ray of chest, 2 views (HCPCS:71046)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Ct scan of chest without contrast (HCPCS:71250)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Blood creatinine level (HCPCS:82565)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Blood test, clotting time (HCPCS:85610)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Red blood count, automated test (HCPCS:85045)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Ct scan of head or brain before and after contrast (HCPCS:70470)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Heart muscle strain imaging (HCPCS:93356)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Declotting of central venous tube (HCPCS:36593)

The enumeration date for this NPI number is 4/11/2013 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.